Abizer Gaslightwala is of Akari Therapeutics Plc. Currently has a direct ownership of 35,860 shares of AKTX, which is worth approximately $39,087. The most recent transaction as insider was on Jan 10, 2025, when has been sold 11,439 shares (American Depository Shares representing Ordinary Shares) at a price of $1.22 per share, resulting in proceeds of $13,955. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.9K
n/a 3M change
n/a 12M change
Total Value Held $39,087

Abizer Gaslightwala Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 10 2025
BUY
Grant, award, or other acquisition
$13,955 $1.22 p/Share
11,439 Added 24.18%
35,860 American Depository Sh...
Jan 03 2025
BUY
Grant, award, or other acquisition
-
1,720,000 Added 2.34%
71,720,000 Ordinary shares, par v...
Dec 27 2024
BUY
Grant, award, or other acquisition
-
40,000,000 Added 36.36%
70,000,000 Ordinary shares, par v...
Dec 26 2024
BUY
Grant, award, or other acquisition
-
30,000,000 Added 50.0%
30,000,000 Ordinary shares, par v...
AG

Abizer Gaslightwala

Boston, MA

Track Institutional and Insider Activities on AKTX

Follow Akari Therapeutics Plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKTX shares.

Notify only if

Insider Trading

Get notified when an Akari Therapeutics PLC insider buys or sells AKTX shares.

Notify only if

News

Receive news related to Akari Therapeutics Plc

Track Activities on AKTX